Our Products

Prescribing Information GB
GB ONLY CONTENT
MAT-XU-2302443 (v1.0)
Date of preparation: June 2023

Prescribing Information GB
Prescribing Information NI
MAT-XU-2200954 (v3.0)
Date of preparation: October 2023
---Copy.png/jcr:content/AUBAGIO_logo_RGB%20(1)%20-%20Copy.png 767w, /.imaging/webp/sanofi-platform/img620x465/dam/hcp-portal-uk/Products/product-card-logos/resized-logo/resized-logo/400x300/AUBAGIO_logo_RGB-(1)---Copy.png/jcr:content/AUBAGIO_logo_RGB%20(1)%20-%20Copy.png 1200w)
Prescribing Information GB
Prescribing Information NI
MAT-XU-2200676 (v4.0)
Date of preparation: April 2023


Prescribing Information GB
Prescribing Information NI
MAT-GB-2105168 (v6.0)
Date of preparation: October 2023

Prescribing Information GB
Prescribing Information NI
MAT-XU-2204064 (v3.0)
Date of preparation: November 2023

Prescribing Information GB
Prescribing Information NI
MAT-XU-2204065 (v2.0)
Date of preparation: January 2023

Clexane
enoxaparin
Prescribing Information UK
MAT-XU-2204397 (v2.0)
Date of preparation: May 2023

Prescribing Information GB
Prescribing Information NI
MAT-GB-2105812 (v4.0)
Date of preparation: May 2023

Prescribing Information GB
Prescribing Information NI
MAT-XU-2201444 (v3.0)
Date of preparation: January 2023
.png/jcr:content/Lemtrada-triangle-logo-product-card%20(1).png 767w, /.imaging/webp/sanofi-platform/img620x465/dam/hcp-portal-uk/Products/product-card-logos/resized-logo/resized-logo/400x300/Lemtrada-triangle-logo-product-card-(1).png/jcr:content/Lemtrada-triangle-logo-product-card%20(1).png 1200w)
Prescribing Information GB
Prescribing Information NI
MAT-XU-2200680 (v2.0)
Date of preparation: August 2022

Prescribing Information GB
GB ONLY CONTENT
MAT-XU-2301129 (v1.0)
Date of preparation: May 2023
.png/jcr:content/Myozyme-logo%20(1).png 767w, /.imaging/webp/sanofi-platform/img620x465/dam/hcp-portal-uk/Products/product-card-logos/resized-logo/resized-logo/400x300/Myozyme-logo-(1).png/jcr:content/Myozyme-logo%20(1).png 1200w)
Prescribing Information GB
Prescribing Information NI
MAT-GB-2105179 (v3.0)
Date of preparation: February 2023

NEXVIADYME
avalglucosidase alfa
Prescribing Information GB
GB ONLY CONTENT
MAT-XU-2203480 (v5.0)
Date of preparation: September 2023

PRALUENT
alirocumab
Prescribing Information GB
Prescribing Information NI
MAT-XU-2204604 (v2.0)
Date of preparation: March 2023




Prescribing Information GB
GB ONLY CONTENT
MAT-XU-2202695 (v3.0)
Date of preparation: June 2023



Prescribing Information GB
GB ONLY CONTENT
MAT-XU-2301126 (v1.0)
Date of preparation: May 2023

Prescribing Information GB
Prescribing Information NI
MAT-XU-2302426 (v6.0)
Date of Preparation: October 2023

Prescribing Information GB
GB ONLY CONTENT
MAT-XU-2205461 (v7.0)
Date of preparation: June 2023

.jpg/jcr:content/Vaxelis%C3%82%C2%AE_Global_primary_RGB%20(1).jpg 767w, /.imaging/webp/sanofi-platform/img620x465/dam/hcp-portal-uk/Products/vaccine-images/Vaxelis/Vaxelis®_Global_primary_RGB-(1).jpg/jcr:content/Vaxelis%C3%82%C2%AE_Global_primary_RGB%20(1).jpg 1200w)
Prescribing Information GB
GB ONLY CONTENT
MAT-XU-2301124 (v1.0)
Date of preparation: May 2023
▼ This drug is subject to additional monitoring, the reporting of suspected adverse reactions associated with this drug is a priority.
MAT-GB-2105466 (v1.0)
Date of preparation: February 2022